Evidence map›Paper›PMID 26688513›Full record

ArticleInternational journal of surgery case reports2016

Gallbladder's clear cell renal carcinoma metastasis: A case report.

Carolina Castro Ruiz, Claudio Pedrazzoli, Stefano Bonacini

Open access · goldAbstract read
In one paragraph

Article in International journal of surgery case reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Imaging of gallbladder metastasis.Insights into imaging · 2021
    Review
  2. Article
  3. Article
  4. Renal Cell Carcinoma Metastatic to the Gallbladder.Journal of gastrointestinal cancer · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Carolina Castro RuizChirurgia I a prevalente indirizzo Oncologico Ricostruttivo, Dipartimento Chirurgia Generale e Specialistiche, Arcispedale S. Maria Nuova, IRCCS, Viale Umberto I, 50, 42123 Reggio Emilia, Italy. Electronic address: carolina.castroruiz85@gmail.com.
Claudio PedrazzoliChirurgia I a prevalente indirizzo Oncologico Ricostruttivo, Dipartimento Chirurgia Generale e Specialistiche, Arcispedale S. Maria Nuova, IRCCS, Viale Umberto I, 50, 42123 Reggio Emilia, Italy. Electronic address: claudio.pedrazzoli@asmn.re.it.
Stefano BonaciniChirurgia I a prevalente indirizzo Oncologico Ricostruttivo, Dipartimento Chirurgia Generale e Specialistiche, Arcispedale S. Maria Nuova, IRCCS, Viale Umberto I, 50, 42123 Reggio Emilia, Italy. Electronic address: stefano.bonacini@asmn.re.it.
Istituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionClear cell renal cell carcinoma (ccRCC) is well known for its propensity to metastasize to unusual sites, even after 10 years. Gallbladder metastases are extremely rare, being found in approximately 0.6% of cases, at autopsy. CASE PRESENTATION: A 51-year-old man with a history of right ccRCC underwent total nephrectomy with extended lymphadenectomy, in another Hospital. Three years later, he was hospitalized at our Hospital, with gallbladder metastasis detected during a follow-up CT scan. At clinical examination, the patient did not present any symptoms or signs of gallbladder disease. Several imaging tests were performed to better characterize the lesion. A successful cholecystectomy and hepatic resection of 4b segment were performed, obtaining a R0 resection. The clinical course was uneventful, without any complications. After a 7-month follow-up, the patient is free from disease. DISCUSSION: A typical metastases are those located in a site other than thoracic, skeletal, hepatic, adrenal or encephalic tissue. Cholecystectomy with R0 resection has demonstrated to be the only factor increasing survival, mainly in isolated cases of metastasis, providing an overall 35-60% survival rate at 5 years.

conclusionIn the follow-up of patients with a positive history of renal cell carcinoma specially clear cell subtype, all new finding should be taken into account as possible metastases. We ought to consider US and CT-scan behavior of gallbladder metastatic disease in order to orientate our diagnosis. Surgery for metastatic gallbladder disease of renal origin seems to be a feasible therapy which is capable of increasing patients' overall survival.

Indexed as

DiagnosisGallbladder metastatic diseaseRenal cell carcinomaTreatment

Identifiers

PMID26688513
PMCPMC4701866
OpenAlexW2175664011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.